Recommendations on alteplase and tenecteplase from ESO

After the discussion of the European Stroke Organization (ESO) Executive Committee and Boehringer Ingelheim (BI)  on the current alteplase and tenecteplase shortage on 11.07.2022, you can find the updates and recommendations made by ESO about the current situation from the link.